Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Estrogen receptor alpha gene variant, PvuII (rs2234693), as a potential pharmacogenetic biomarker for aneurysmal subarachnoid hemorrhage in postmenopausal women

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) occurs more often in postmenopausal women than in men. Estrogen plays an important role in vascular homeostasis. Our aim was to elucidate whether a drop in circulating estradiol in conjunction with variants of estrogen receptor genes have a role in female gender susceptibility to aSAH. A total of 709 subjects were enrolled (349 aSAH patients, 360 controls) and genotyped for rs2234693 or PvuII (intron 1, T>C) in the ESR1 gene and rs4986938 or AluI (exon 8, 1730G>A) of ESR2 gene by PCR-RFLP. Serum estradiol was estimated by ELISA. Estrogen receptor gene expression was studied by qRT-PCR. Logistic regression analysis indicated a significant recessive effect of the T allele of PvuII on aSAH in females, and this association remained statistically significant even after adjusting for confounders (OR 1.702, CI 95% 1.062, 2.726, P value = 0.027). ESR1 gene expression was significantly reduced (P value = 0.0089) in subjects carrying PvuII T allele. In postmenopausal women with TT genotype and low serum estradiol, the odds for developing aSAH were found to be 3.5-fold increase compared with premenopausal women (CI 95% 1.424–8.828, P value = 0.0074). However, this variant showed no significant association with aSAH in men. No significant difference was found in genotype and allelic distribution of AluI polymorphism in ESR2 gene, between patients and controls. We propose that the PvuII T allele could be a potential pharmacogenetic marker for strategizing personal medicine for preventing aSAH in postmenopausal women with low circulating estradiol. Further larger studies in other population are warranted.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Relative expression of estrogen receptor alpha mRNA levels (ESR1 gene expression) and the correlation between ESR1 gene expression and estradiol levels.
Fig. 2: The proposed model for the association between ESR1 gene variant, estradiol levels, ER gene expression, and aSAH in postmenopausal women.

Similar content being viewed by others

References

  1. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365–72.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med. 2002;346:967–74.

    Article  CAS  PubMed  Google Scholar 

  3. Turan N, Heider RA, Zaharieva D, Ahmad FU, Barrow DL, Pradilla G. Sex differences in the formation of intracranial aneurysms and incidence and outcome of subarachnoid hemorrhage: review of experimental and human studies. Transl Stroke Res. 2016;7:12–9.

    Article  PubMed  Google Scholar 

  4. Mariah RA, Baghdadi H, Ahmed KE, Mostafa N, Ayat Ahemd MM, Nansour T. et al. Frequency of estrogen receptor-1 (ESR-1) gene polymorphism (PvuII and XbaI) in patients with coronary artery disease. Am J Med Biol Res. 2016;4:5–9.

    CAS  Google Scholar 

  5. Prossnitz ER, Arterburn JB. International Union of Basic and Clinical Pharmacology. XCVII. G protein-coupled estrogen receptor and its pharmacologic modulators. Pharmacol Rev. 2015;67:505–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Ramesh SS, Christopher R, Indira Devi B, Bhat DI. The vascular protective role of oestradiol: a focus on postmenopausal oestradiol deficiency and aneurysmal subarachnoid haemorrhage. Biol Rev Camb Philos Soc. 2019. https://doi.org/10.1111/brv.12541.

  7. Stirone C, Duckles SP, Krause DN. Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab. 2003;284:E184–92.

    Article  CAS  PubMed  Google Scholar 

  8. Strand M, Söderström I, Wiklund PG, Hallmans G, Weinehall L, Söderberg S, et al. Estrogen receptor alpha gene polymorphisms and first-ever intracerebral hemorrhage. Cerebrovasc Dis. 2007;24:500–8.

    Article  CAS  PubMed  Google Scholar 

  9. Rebaï M, Rebaï A. In silico characterization of functional SNP within the oestrogen receptor gene. J Genet. 2016;95:865–74.

    Article  PubMed  Google Scholar 

  10. Markoula S, Milionis H, Lazaros L, Spengos K, Vassilopoulou S, Chatzistefanidis D, et al. Associations of ESR2 AluI (G/A) polymorphism with ischemic stroke in Caucasians. J Neurol Sci. 2012;316:126–30.

    Article  CAS  PubMed  Google Scholar 

  11. Markoula S, Xita N, Lazaros L, Giannopoulos S, Kyritsis AP, Georgiou I. Estrogen receptor alpha gene haplotypes and diplotypes in the risk of stroke. Stroke. 2008;39:e172–3.

    Article  CAS  PubMed  Google Scholar 

  12. Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988;68:985–6.

  13. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1–9.

    Article  CAS  PubMed  Google Scholar 

  14. Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech. 2013;24:224–31.

    PubMed  PubMed Central  Google Scholar 

  15. Turner S, Armstrong LL, Bradford Y, Carlson CS, Crawford DC, Crenshaw AT, et al. Quality control procedures for genome-wide association studies. Curr Protoc Hum Genet. 2011. https://doi.org/10.1002/0471142905.hg0119s68.

  16. Kongable GL, Lanzino G, Germanson TP, Trukowski LL, Alves WM, Torner JC, et al. Gender-related differences in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1996;84:43–8.

    Article  CAS  PubMed  Google Scholar 

  17. O’Lone R, Knorr K, Jaffe IZ, Schaffer ME, Martini PG, Karas RH, et al. Estrogen receptors α and ß mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol Endocrinol. 2007;21:1281–96.

    Article  PubMed  Google Scholar 

  18. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation. 2002;105:1879–82.

    Article  CAS  PubMed  Google Scholar 

  19. Putnik M, Zhao C, Gustafsson JA, Dahlman-Wright K. Effects of two common polymorphisms in the 3’ untranslated regions of estrogen receptor beta on mRNA stability and translatability. BMC Genet. 2009;10:55.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lazaros L, Markoula S, Xita N, Giannopoulos S, Gogou P, Lagos G, et al. Association of estrogen receptor-alpha gene polymorphisms with stroke risk in patients with metabolic syndrome. Acta Neurol Scand. 2008;117:186–90.

    Article  CAS  PubMed  Google Scholar 

  21. Shearman AM. Oestrogen receptor genetics: a needle that cuts through many haystacks? Eur Heart J. 2006;27:1519–20.

    Article  CAS  PubMed  Google Scholar 

  22. Munshi A, Sharma V, Kaul S, Al Hazzani A, Alshatwi AA, Manohar VR, et al. Estrogen receptor α genetic variants and the risk of stroke in a South Indian population from Andhra Pradesh. Clin Chim Acta. 2010;411:1817–21.

    Article  CAS  PubMed  Google Scholar 

  23. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol. 2005;153:327–34.

    Article  CAS  PubMed  Google Scholar 

  24. Chen M, Ouyang B, Goldstein-Smith L, Feldman L. Oral contraceptive and hormone replacement therapy in women with cerebral aneurysms. J NeuroInterv Surg. 2011;3:163–6.

    Article  PubMed  Google Scholar 

  25. Mhurchu CN, Anderson C, Jamrozik K, Hankey G, Dunbabin D. The hormonal factors and risk of aneurysmal subarachnoid hemorrhage: an international population-based, case–control study. Stroke. 2001;32:606–12.

    Article  CAS  PubMed  Google Scholar 

  26. Khalil RA. Estrogen, vascular estrogen receptor and hormone therapy inpostmenopausal vascular disease. Biochem Pharmacol. 2013;86:1627–42.

    Article  CAS  PubMed  Google Scholar 

  27. Ryan J, Canonico M, Carcaillon L, Carrière I, Scali J, Dartigues JF, et al. Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study. PLoS ONE. 2012;7:e34112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Marini H, Currò M, Adamo EB, Polito F, Ferlazzo N, Bitto A, et al. The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women. Gene. 2012;508:206–10.

    Article  CAS  PubMed  Google Scholar 

  29. Domingues-Montanari S, Subirana I, Tomás M, Marrugat J, Sentí M. Association between ESR2 genetic variants and risk of myocardial infarction. Clin Chem. 2008;54:1183–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the Indian Council of Medical Research (ICMR), New Delhi, India and the Department of Science and Technology (DST), New Delhi, India for the funding, and the Vision Group on Science and Technology (VGST), Karnataka, India for providing qRT-PCR equipment. We also thank all the volunteers who consented to participate in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rita Christopher.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramesh, S.S., Christopher, R., Devi, B.I. et al. Estrogen receptor alpha gene variant, PvuII (rs2234693), as a potential pharmacogenetic biomarker for aneurysmal subarachnoid hemorrhage in postmenopausal women. Pharmacogenomics J 20, 655–663 (2020). https://doi.org/10.1038/s41397-020-0155-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41397-020-0155-4

Search

Quick links